CARSON CITY, Nev. & LONDON–(BUSINESS WIRE)–AscellaHealth:
WHO: Newly formed organization, The Committee to Restore Nymox Shareholder Value, Calls for Shareholder Support
WHAT: Following the distribution of a press release by Nymox Pharmaceutical Corporation (the Company) regarding a NASDAQ Hearing Delist Decision at the open of business on July 7, 2023, rebuttal letters are being issued to all Company shareholders. Access the documents at www.crnsv.com
When: July 10, 2023
Where: CARSON CITY, Nevada; LONDON
Why: Summary of Rebuttal Letters:
-
Lack of Company Leadership:
- Termination of key management as officers of the company and subsequent failure to properly notify shareholders in violation of SEC rules governing 6-K filings.
- Operational mismanagement, disclosure issues and market fiasco.
- Shareholder uncertainty and confusion resulting from NASDAQ delisting and recent volatility of stock price.
- Inability to competently engage with US Food and Drug Administration.
- Failure of CEO to execute and fulfill key components of his role including, to: adhere to the advice and expertise of counsel and industry experts; appropriately fund the company; or adequately engage the Company shareholders.
-
Inability to Realize the Potential for Valuable and Promising Results Through Relationship with AscellaHealth LLC: a highly respected global healthcare and specialty pharmacy solutions company with expertise to help commercialize the Company’s benign prostatic hyperplasia (BPH) product.
- Failed opportunity to leverage the committed funding, expertise, and experience of AscellaHealth to successfully position pharmaceuticals, drugs, and biotech products worldwide.
- Absence of strategic marketing plan and communications with internal and external audiences to implement effective positioning to seek approval of the Company’s first in class drug NYMOZARFEX to treat the symptoms of BPH. BPH is one of the most common conditions affecting middle aged and elderly men throughout the world.
-
Lack of Solution or Plan for Financial Recovery of Shareholder Value
- Breakdown in alignment with AscellaHealth negates financial commitment and expertise to restore value to the Company in anticipation of the Danish market approval decision.
- Steady decline in stock value, while it was documented the CEO received an inflated remuneration package and personally sold over $4,000,000 worth of stock in the last 5 years.
- AscellaHealth, LLC potential partnership terminated by CEO, prior to discussion with key board members or other officers.
Contacts
Chris Riley
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Automotive / EVs, Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- BlockOffsets. Modernizing Environmental Offset Ownership. Access Here.
- Source: https://www.fintechnews.org/rebuttal-letters-issued-to-shareholders-of-nymox-pharmaceutical-corp-nymx-q/
- :is
- 000
- 10
- 2023
- 22
- 7
- a
- access
- adequately
- adhere
- administration
- advice
- affecting
- aged
- All
- an
- and
- anticipation
- appropriately
- approval
- ARE
- AS
- At
- audiences
- being
- biotech
- board
- Breakdown
- business
- Business Wire
- by
- Calls
- ceo
- Chris
- City
- class
- COM
- commercialize
- commitment
- committed
- committee
- Common
- Communications
- company
- Company’s
- components
- conditions
- confusion
- Corp
- CORPORATION
- counsel
- danish
- decision
- Decline
- DELISTING
- disclosure
- discussion
- distribution
- documents
- drug
- Drugs
- Effective
- Elderly
- engage
- Ether (ETH)
- execute
- experience
- expertise
- experts
- external
- Failed
- Failure
- filings
- financial
- First
- following
- food
- Food and Drug Administration
- For
- formed
- from
- Fulfill
- fund
- funding
- Global
- governing
- healthcare
- hearing
- help
- highly
- his
- HTTPS
- implement
- in
- inability
- Including
- industry
- industry experts
- internal
- Issued
- issues
- IT
- jpg
- July
- Key
- Last
- Leadership
- Leverage
- LLC
- management
- Market
- Marketing
- Members
- Men
- Middle
- mismanagement
- most
- Nasdaq
- NEVADA
- newly
- of
- officers
- on
- ONE
- open
- operational
- Opportunity
- or
- organization
- Other
- over
- package
- Partnership
- Personally
- Pharmaceutical
- pharmaceuticals
- pharmacy
- plan
- plato
- Plato Data Intelligence
- PlatoData
- position
- positioning
- potential
- price
- Prior
- Products
- promising
- properly
- realize
- received
- recent
- recovery
- regarding
- relationship
- remuneration
- respected
- restore
- resulting
- Results
- Role
- rules
- SEC
- Seek
- shareholder
- Shareholders
- sold
- solution
- Solutions
- Specialty
- steady
- stock
- Strategic
- subsequent
- Successfully
- SUMMARY
- Symptoms
- The
- the world
- Through
- throughout
- to
- treat
- Uncertainty
- us
- Valuable
- value
- VIOLATION
- Volatility
- was
- while
- Wire
- with
- world
- worldwide
- worth
- years
- zephyrnet
More from Fintech News
DBS LiveBetter Now Allows Users to Track and Offset Their Carbon Footprint
Source Node: 1381381
Time Stamp: Jun 14, 2022
Is Crypto dead? finance in Web3 needs neither Crypto nor ER
Source Node: 1718637
Time Stamp: Oct 6, 2022
AI will choose Bitcoin as its native currency, predicts Arthur Hayes
Source Node: 2164837
Time Stamp: Jul 10, 2023
Global Magnetron Sputtering Systems Market Report to 2030 – Featuring Buhler, Denton Vacuum, Torr International and ULVAC Among Others – ResearchAndMarkets.com
Source Node: 1924244
Time Stamp: Jan 27, 2023
Singapore and French Regulators Carry Out Joint Cyber Crisis Exercise
Source Node: 1475273
Time Stamp: Jun 19, 2022
EADIC apuesta por la transferencia de conocimiento escuela-empresa/agosto2022
Source Node: 1643450
Time Stamp: Aug 29, 2022
How to take advantage of cryptocurrency welcome bonuses
Source Node: 1722881
Time Stamp: Oct 13, 2022
Understanding Blockchain Technology & Its Implications For Global Finance
Source Node: 2035693
Time Stamp: Mar 28, 2023
Medidata Announces New Data Integration Solutions to Accelerate Clinical Trials: Clinical Data Studio and Health Record Connect
Source Node: 2374611
Time Stamp: Nov 8, 2023
The Essential Role of CAD Software in Modern Mechanical Design
Source Node: 2524865
Time Stamp: Mar 24, 2024
Unveiling 2024’s hottest and trending Meme Coins: ApeMax, DogeCoin, Shiba Inu, Bonk, and Pepe
Source Node: 2502480
Time Stamp: Mar 2, 2024